Literature DB >> 22065097

Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.

C Bengtsson1, M-L Ohman, O Nived, S Rantapää Dahlqvist.   

Abstract

INTRODUCTION: An increased rate of cardiovascular disease (CVD) has been suggested in patients with systemic lupus erythematosus (SLE). The risk for myocardial infarction (MI), coronary artery disease and stroke has been reported as particularly prevalent in younger females compared with the reference population. This study was performed to analyse the standard incidence ratio (SIR) of and predictors for cardiovascular events (CVEs) in patients with SLE from northern Sweden, with a fairly homogenous population.
METHODS: In 2000 all prevalent patients with SLE (≥4 American College of Rheumatology [ACR] criteria; n = 277) from the four northern-most counties of Sweden were assessed with clinical and laboratory analyses. Seven years follow-up data concerning MI and stroke were extracted from the national registers of hospitalization and death in Sweden. The incidence ratio among the patients was compared with that for the general population from the same catchment area using data from the same register and Statistics Sweden. To identify time to event and CVE predictors, two matched controls for each patient were used and disease related variables as CVD predictors.
RESULTS: The SIR for a CVE was 1.27 (95% CI 0.82-1.87) and for females separately aged 40-49 years was 8.00 (95% CI 1.65-23.38). The overall SIR for MI was 2.31 (95% CI 1.34-3.7), for females overall was 1.75 (95% CI 0.84-3.22) and for females aged between 40 and 49 years was 8.7 (95% CI 1.1-31.4). The time to an event was significantly shorter among SLE patients (p < 0.001) and was predicted by hypertension adjusted for smoking and disease. High SLEDAI and anti-cardiolipin IgG antibodies predicted an event in Cox proportional hazards regression models adjusted for age and previous MI. Diabetes, smoking ever and sex did not affect the prediction models.
CONCLUSION: The risk of a CVE, or MI, was eight- or nine-fold greater among middle-aged female SLE patients. Time to event was significantly shorter and CVE was associated with SLE-related factors including hypertension and age.

Entities:  

Mesh:

Year:  2011        PMID: 22065097     DOI: 10.1177/0961203311425524

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  40 in total

Review 1.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

Review 2.  Magnetic resonance imaging for characterizing myocardial diseases.

Authors:  Maythem Saeed; Hui Liu; Chang-Hong Liang; Mark W Wilson
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-31       Impact factor: 2.357

3.  Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients.

Authors:  Gregory Katz; Nathaniel R Smilowitz; Ashira Blazer; Robert Clancy; Jill P Buyon; Jeffrey S Berger
Journal:  Mayo Clin Proc       Date:  2019-07-11       Impact factor: 7.616

4.  Peak strain dispersion within the left ventricle detected by two-dimensional speckle tracking in patients with uncomplicated systemic lupus erythematosus.

Authors:  Chunmei Li; Kun Li; Miao Yuan; Wenjuan Bai; Li Rao
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-04       Impact factor: 2.357

5.  Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.

Authors:  Elisabet Svenungsson; Daniel Engelbertsen; Maria Wigren; Johanna T Gustafsson; Iva Gunnarsson; Kerstin Elvin; Kerstin Jensen-Urstad; Gunilla Nordin Fredrikson; Jan Nilsson
Journal:  Clin Exp Immunol       Date:  2015-06-22       Impact factor: 4.330

6.  Decreased heart rate variability in patients with psoriatic arthritis.

Authors:  Inna Gaydukova; Andrey Rebrov; Natalia Nikitina; Denis Poddubnyy
Journal:  Clin Rheumatol       Date:  2012-06-07       Impact factor: 2.980

Review 7.  Hypertension in connective tissue disease.

Authors:  Qiang Luo; Yiwen Zhang; Xiaoqian Yang; Li Qin; Han Wang
Journal:  J Hum Hypertens       Date:  2022-05-03       Impact factor: 3.012

Review 8.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 9.  Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.

Authors:  Allison B Reiss; Benna Jacob; Saba Ahmed; Steven E Carsons; Joshua DeLeon
Journal:  Inflammation       Date:  2021-04-05       Impact factor: 4.092

10.  Risk of vascular events in patients with polymyalgia rheumatica.

Authors:  Adam T Hancock; Christian D Mallen; Sara Muller; John Belcher; Edward Roddy; Toby Helliwell; Samantha L Hider
Journal:  CMAJ       Date:  2014-07-28       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.